Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening

TASK-3 is a two-pore domain potassium (K2P) channel highly expressed in the hippocampus, cerebellum, and cortex. TASK-3 has been identified as an oncogenic potassium channel and it is overexpressed in different cancer types. For this reason, the development of new TASK-3 blockers could influence the pharmacological treatment of cancer and several neurological conditions. In the present work, we searched for novel TASK-3 blockers by using a virtual screening protocol that includes pharmacophore modeling, molecular docking, and free energy calculations. With this protocol, 19 potential TASK-3 blockers were identified. These molecules were tested in TASK-3 using patch clamp, and one blocker (DR16) was identified with an IC50 = 56.8 ± 3.9 μM. Using DR16 as a scaffold, we designed DR16.1, a novel TASK-3 inhibitor, with an IC50 = 14.2 ± 3.4 μM. Our finding takes on greater relevance considering that not many inhibitory TASK-3 modulators have been reported in the scientific literature until today. These two novel TASK-3 channel inhibitors (DR16 and DR16.1) are the first compounds found using a pharmacophore-based virtual screening and rational drug design protocol.

[1]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[2]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[3]  Zhenwei Su,et al.  Mechanosensitivity is mediated directly by the lipid membrane in TRAAK and TREK1 K+ channels , 2014, Proceedings of the National Academy of Sciences.

[4]  P. Stansfeld,et al.  The molecular basis for an allosteric inhibition of K+-flux gating in K2P channels , 2019, eLife.

[5]  Edmund M Talley,et al.  TASK-1, a Two–Pore Domain K+ Channel, Is Modulated by Multiple Neurotransmitters in Motoneurons , 2000, Neuron.

[6]  Nir London,et al.  Virtual Screening for UDP-Galactopyranose Mutase Ligands Identifies a New Class of Antimycobacterial Agents. , 2015, ACS chemical biology.

[7]  Ricardo L. Mancera,et al.  Expanded Interaction Fingerprint Method for Analyzing Ligand Binding Modes in Docking and Structure-Based Drug Design , 2004, J. Chem. Inf. Model..

[8]  M. Sansom,et al.  A hydrophobic barrier deep within the inner pore of the TWIK-1 K2P potassium channel , 2014, Nature Communications.

[9]  W. González,et al.  Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine , 2019, International journal of molecular sciences.

[10]  D. Bayliss,et al.  Two-Pore-Domain (Kcnk) Potassium Channels: Dynamic Roles in Neuronal Function , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[11]  Ernest B. Campbell,et al.  Physical mechanism for gating and mechanosensitivity of the human TRAAK K+ channel , 2014, Nature.

[12]  David Ramírez,et al.  Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data? , 2018, Molecules.

[13]  Julio Caballero,et al.  Is It Reliable to Use Common Molecular Docking Methods for Comparing the Binding Affinities of Enantiomer Pairs for Their Protein Target? , 2016, International journal of molecular sciences.

[14]  R. Friesner,et al.  The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling , 2011, Proteins.

[15]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[16]  D. Minor,et al.  K2P2.1(TREK-1):activator complexes reveal a cryptic selectivity filter binding site , 2017, Nature.

[17]  Sven G Meuth,et al.  Contribution of TWIK-Related Acid-Sensitive K+ Channel 1 (TASK1) and TASK3 Channels to the Control of Activity Modes in Thalamocortical Neurons , 2003, The Journal of Neuroscience.

[18]  R. Abagyan,et al.  Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.

[19]  A. Mittal,et al.  Pharmacophore based virtual screening, molecular docking and biological evaluation to identify novel PDE5 inhibitors with vasodilatory activity. , 2014, Bioorganic & Medicinal Chemistry Letters.

[20]  P. Domínguez,et al.  Differential expression of two-pore domain potassium channels in rat cerebellar granule neurons. , 2014, Biochemical and biophysical research communications.

[21]  R. MacKinnon,et al.  Crystal Structure of the Human K2P TRAAK, a Lipid- and Mechano-Sensitive K+ Ion Channel , 2012, Science.

[22]  Exploration of new scaffolds as potential MAO-A inhibitors using pharmacophore and 3D-QSAR based in silico screening. , 2011, Bioorganic & medicinal chemistry letters.

[23]  W Patrick Walters,et al.  Going further than Lipinski's rule in drug design , 2012, Expert opinion on drug discovery.

[24]  An allosteric ligand-binding site in the extracellular cap of K2P channels , 2017, Nature Communications.

[25]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[26]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[27]  D. Bayliss,et al.  Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact. , 2008, Trends in pharmacological sciences.

[28]  Detlef Bockenhauer,et al.  Potassium leak channels and the KCNK family of two-p-domain subunits , 2001, Nature Reviews Neuroscience.

[29]  Joseph F. Cotten,et al.  Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore , 2015, Molecular Pharmacology.

[30]  J. Morán,et al.  Novel TASK channels inhibitors derived from dihydropyrrolo[2,1-a]isoquinoline , 2014, Neuropharmacology.

[31]  A. Gourine,et al.  A Role for TASK-1 (KCNK3) Channels in the Chemosensory Control of Breathing , 2008, The Journal of Neuroscience.

[32]  E. Campbell,et al.  Domain-swapped chain connectivity and gated membrane access in a Fab-mediated crystal of the human TRAAK K+ channel , 2013, Proceedings of the National Academy of Sciences.

[33]  Edmund M Talley,et al.  The TASK family: two-pore domain background K+ channels. , 2003, Molecular interventions.

[34]  W. González,et al.  TASK Channels Pharmacology: New Challenges in Drug Design. , 2019, Journal of medicinal chemistry.

[35]  David E. Clark,et al.  PRO_SELECT: Combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology , 1997, J. Comput. Aided Mol. Des..

[36]  Steven V. Fox,et al.  Discovery of a Pharmacologically Active Antagonist of the Two‐Pore‐Domain Potassium Channel K2P9.1 (TASK‐3) , 2012, ChemMedChem.

[37]  W. González,et al.  Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels. , 2017, Molecular pharmaceutics.

[38]  Minoru Yoshida,et al.  Identification of 1, 2, 5-Oxadiazoles as a New Class of SENP2 Inhibitors Using Structure Based Virtual Screening , 2014, J. Chem. Inf. Model..

[39]  J. Kahn,et al.  Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. , 1998, The New England journal of medicine.

[40]  A. Karschin,et al.  TASK-3, a Novel Tandem Pore Domain Acid-sensitive K+Channel , 2000, The Journal of Biological Chemistry.

[41]  Jans H. Alzate-Morales,et al.  Performance of the MM/GBSA scoring using a binding site hydrogen bond network-based frame selection: the protein kinase case. , 2014, Physical chemistry chemical physics : PCCP.

[42]  D. Bayliss,et al.  TASK-1 is a highly modulated pH-sensitive 'leak' K(+) channel expressed in brainstem respiratory neurons. , 2001, Respiration physiology.

[43]  D. Minor,et al.  Transmembrane Helix Straightening and Buckling Underlies Activation of Mechanosensitive and Thermosensitive K2P Channels , 2014, Neuron.

[44]  Giulio Rastelli,et al.  Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA , 2009, J. Comput. Chem..

[45]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[46]  M. Catalán,et al.  The Insensitivity of TASK-3 K2P Channels to External Tetraethylammonium (TEA) Partially Depends on the Cap Structure , 2018, International journal of molecular sciences.

[47]  D. Bayliss,et al.  Motoneuronal TASK Channels Contribute to Immobilizing Effects of Inhalational General Anesthetics , 2010, The Journal of Neuroscience.

[48]  D. Bayliss,et al.  CNS Distribution of Members of the Two-Pore-Domain (KCNK) Potassium Channel Family , 2001, The Journal of Neuroscience.

[49]  Steven L Dixon,et al.  PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching , 2006, Chemical biology & drug design.

[50]  Daniel Șterbuleac.  Molecular determinants of chemical modulation of two‐pore domain potassium channels , 2019, Chemical biology & drug design.

[51]  Steven V. Fox,et al.  TASK-3 as a potential antidepressant target , 2011, Brain Research.

[52]  M. Sansom,et al.  A Specific Two-pore Domain Potassium Channel Blocker Defines the Structure of the TASK-1 Open Pore , 2011, The Journal of Biological Chemistry.

[53]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[54]  Todd J. A. Ewing,et al.  DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..

[55]  W. González,et al.  Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea? , 2014, Pflügers Archiv - European Journal of Physiology.

[56]  Péter Enyedi,et al.  Molecular Background of Leak K (cid:1) Currents: Two-Pore Domain Potassium Channels , 2010 .

[57]  David Ryan Koes,et al.  ZINCPharmer: pharmacophore search of the ZINC database , 2012, Nucleic Acids Res..

[58]  G. F. Ruda,et al.  K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac , 2015, Science.

[59]  Beiyan Zou,et al.  Identification of novel small molecule modulators of K2P18.1 two-pore potassium channel. , 2014, European journal of pharmacology.

[60]  Vishal Trivedi,et al.  Docking and virtual screening to identify PKC agonists: potentials in anticancer therapeutics. , 2014, Current computer-aided drug design.

[61]  Joseph F. Cotten,et al.  TASK-1 (KCNK3) and TASK-3 (KCNK9) Tandem Pore Potassium Channel Antagonists Stimulate Breathing in Isoflurane-Anesthetized Rats , 2013, Anesthesia and analgesia.

[62]  B. Honig,et al.  On the accuracy of homology modeling and sequence alignment methods applied to membrane proteins. , 2006, Biophysical journal.

[63]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[64]  S. Long,et al.  Crystal Structure of the Human Two–Pore Domain Potassium Channel K2P1 , 2012, Science.

[65]  I. Kuntz,et al.  Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. , 2001, Journal of medicinal chemistry.

[66]  David Ryan Koes,et al.  Pharmer: Efficient and Exact Pharmacophore Search , 2011, J. Chem. Inf. Model..

[67]  Yong Zhao,et al.  Pharmacophore Screening of the Protein Data Bank for Specific Binding Site Chemistry , 2010, J. Chem. Inf. Model..

[68]  Giulio Rastelli,et al.  Structure-based design of potent aromatase inhibitors by high-throughput docking. , 2011, Journal of medicinal chemistry.

[69]  H. Wiendl,et al.  TWIK-related Acid-sensitive K+ Channel 1 (TASK1) and TASK3 Critically Influence T Lymphocyte Effector Functions* , 2008, Journal of Biological Chemistry.

[70]  W. V. van Gunsteren,et al.  A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations , 2001 .